NEWS

ME Therapeutics press releases, media coverage and scientific findings

ME THERAPEUTICS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT AND PROVIDES CORPORATE UPDATE

ME THERAPEUTICS HOLDINGS INC. PROVIDES CORPORATE UPDATES

ME THERAPEUTICS HOLDINGS INC. ANNOUCES LISTING ON THE FRANKFURT STOCK EXCHANGE (FSE) AND THE COMPLETION OF ITS REDESIGNED WEBSITE

ME THERAPEUTICS HOLDINGS INC. Provides An Overview And Update On Current Research And Development Programs

ME THERAPEUTICS HOLDINGS INC. Receives Funding Support For Preclinical Testing Of Prodrug Candidates

ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange

Cancer Research Communications: Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling

ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications

ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate

Keep up to date by subscribing to our mailing list